Global AI In Oncology Market Size, Trends & Growth Opportunity, By Component Type (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others) By Region and Forecast till 2030.
Global AI In Oncology Market
The global AI In Oncology market was valued at USD 1.20 billion in 2022 which expected to reach USD 9.58 billion by 2030 at a CAGR 28.30 % from 2023-2030.
The increasing prevalence of cancer, technological advancements in cancer diagnostics and healthcare infrastructure, and rising demand for early and accurate cancer diagnosis are driving the growth of the AI in oncology market Furthermore, rising public and private sector initiatives to invest in R&D for the introduction of new technologies are expected to drive market growth. Var, for example, raised USD 4.4 million in funding in October 2022 to launch an artificial intelligence-enabled breast cancer screening platform for millions of women.
Impact of COVID-19
The COVID-19 pandemic had a positive impact on the market because it significantly increased demand for the use of AI in oncology as movement restrictions were imposed globally in hospitals and homecare settings. Patients' diagnosis, care, and treatment were some of the major challenges as a result of the lockdown and travel restrictions, which increased the need to develop products that can help in providing solutions in remote locations and at an early stage. Furthermore, due to a shortage of medical professionals, the use of artificial intelligence (AI) has grown even more in order to provide better results to patients.
Market Segmentation
The Global AI In Oncology Market is segmented into Component Type, Cancer Type, Distribution Channel and Growing System. By Component Type such as Software Solutions, Hardware, Services. By Cancer Type such as Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others. By Treatment Type such as Chemotherapy, Radiotherapy, Immunotherapy, Others.
Regional Analysis
Global AI In Oncology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the AI In Oncology market in North America is expected to grow at the fastest CAGR. due to the presence of well-developed digital infrastructure, favorable regulatory and reimbursement policies, and rising government initiatives to boost the adoption of AI technology in the healthcare industry. The rising prevalence of various cancers is driving the need for advanced therapeutics and diagnostics, which is fueling regional market growth. Sanofi entered into a collaboration with Owkin Inc. in November 2021, investing USD 180 million in Owkin's AI to advance the oncology pipeline. In addition, in February 2023, M2Gen announced a collaboration with Zephyr AI to advance drug and target discovery for precision oncology treatments.
Key Players
Various key players are listed in this report such as Azra AI, IBM, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies
Market Taxonomy
By Component Type
• Software Solutions
• Hardware
• Services
By Cancer Type
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Others
By Treatment Type
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global AI In Oncology Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global AI In Oncology Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global AI In Oncology Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global AI In Oncology Market, By Component Type
5.1 Y-o-Y Growth Comparison, By Component Type
5.2 Global AI In Oncology Market Share Analysis, By Component Type
5.3 Global AI In Oncology Market Size and Forecast, By Component Type
5.3.1 Software Solutions
5.3.2 Hardware
5.3.3 Services
6 Global AI In Oncology Market, By Cancer Type
6.1 Y-o-Y Growth Comparison, By Cancer Type
6.2 Global AI In Oncology Market Share Analysis, By Cancer Type
6.3 Global AI In Oncology Market Size and Forecast, By Cancer Type
6.3.1 Breast Cancer
6.3.2 Lung Cancer
6.3.3 Prostate Cancer
6.3.4 Colorectal Cancer
6.3.5 Brain Tumor
6.3.6 Others
7 Global AI In Oncology Market, By Treatment Type
7.1 Y-o-Y Growth Comparison, By Treatment Type
7.2 Global AI In Oncology Market Share Analysis, By Treatment Type
7.3 Global AI In Oncology Market Size and Forecast, By Treatment Type
7.3.1 Chemotherapy
7.3.2 Radiotherapy
7.3.3 Immunotherapy
7.3.4 Others
8 Global AI In Oncology Market, By Region
8.1 Global AI In Oncology Market Share Analysis, By Region
8.2 Global AI In Oncology Market Share Analysis, By Region
8.3 Global AI In Oncology Market Size and Forecast, By Region
9 North America AI In Oncology Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America AI In Oncology Market Share Analysis, By Component Type
9.3 North America AI In Oncology Market Size and Forecast, By Cancer Type
9.4 North America AI In Oncology Market Size and Forecast, By Treatment Type
9.6 North America AI In Oncology Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe AI In Oncology Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe AI In Oncology Market Share Analysis, By Component Type
10.3 Europe AI In Oncology Market Size and Forecast, By Cancer Type
10.4 Europe AI In Oncology Market Size and Forecast, By Treatment Type
10.6 Europe AI In Oncology Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific AI In Oncology Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific AI In Oncology Market Share Analysis, By Component Type
11.3 Asia Pacific AI In Oncology Market Size and Forecast, By Cancer Type
11.4 Asia Pacific AI In Oncology Market Size and Forecast, By Treatment Type
11.6 Asia Pacific AI In Oncology Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America AI In Oncology Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America AI In Oncology Market Share Analysis, By Component Type
12.3 Latin America AI In Oncology Market Size and Forecast, By Cancer Type
12.4 Latin America AI In Oncology Market Size and Forecast, By Treatment Type
12.6 Latin America AI In Oncology Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East AI In Oncology Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East AI In Oncology Market Share Analysis, By Component Type
13.3 Middle East AI In Oncology Market Size and Forecast, By Cancer Type
13.4 Middle East AI In Oncology Market Size and Forecast, By Treatment Type
13.6 Middle East AI In Oncology Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Azra AI
15.1.1 Overview
15.1.2 Component Types
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. IBM
15.2.1 Overview
15.2.2 Component Types
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Siemens Healthcare GmbH
15.3.1 Overview
15.3.2 Component Types
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Intel Corporation
15.4.1 Overview
15.4.2 Component Types
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 GE HealthCare
15.5.1 Overview
15.5.2 Component Types
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 NVIDIA Corporation
15.6.1 Overview
15.6.2 Component Types
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Digital Diagnostics Inc.
15.7.1 Overview
15.7.2 Component Types
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 ConcertAI
15.8.1 Overview
15.8.2 Component Types
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Median Technologies
15.9.1 Overview
15.9.2 Component Types
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
